Tsuyoshi Isawa

22PUBLICATIONS
38CO-AUTHORS
PharmacogenomicsCardiology (incl. cardiovascular diseases)Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedElectrometallurgy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 18, 2026
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki

|Sep 24, 2025
Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation.

Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto

|May 14, 2025
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial.

Tetsuya Ishikawa, Masahiro Natsuaki, Hirotoshi Watanabe

|Jan 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial.

Takenori Domei, Ko Yamamoto, Masahiro Natsuaki

|Oct 24, 2024
An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial.

Ko Yamamoto, Masahiro Natsuaki, Hirotoshi Watanabe

Pageof 4